Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
C.R. Bard agrees to pay $200 million up front and another $80 million in possible milestones for Medafor and its plant-based Arista hemostatic agent.
St. Jude Medical acquires Endosense and its TactiCath force-sensing ablation catheter in a deal worth up to $331 million.
Boston Scientific’s latest legal updates provides some insight into a possible end in the long-running Guidant battles, a locking of arms in the Guidezilla disputes and minor progress in a few other litigations.